SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31 | -8.8% | 19,220 | +70.1% | 0.00% | -25.0% |
Q2 2023 | $34 | +61.9% | 11,300 | +197.4% | 0.00% | +100.0% |
Q1 2023 | $21 | 0.0% | 3,800 | -2.6% | 0.00% | 0.0% |
Q4 2022 | $21 | -99.9% | 3,900 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $25,000 | +92.3% | 3,900 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $13,000 | -51.9% | 3,900 | -2.5% | 0.00% | 0.0% |
Q1 2022 | $27,000 | -47.1% | 4,000 | -68.3% | 0.00% | -50.0% |
Q4 2021 | $51,000 | -10.5% | 12,600 | -17.4% | 0.00% | 0.0% |
Q3 2021 | $57,000 | -25.0% | 15,261 | +376.9% | 0.00% | -50.0% |
Q2 2021 | $76,000 | +300.0% | 3,200 | -3.0% | 0.00% | +300.0% |
Q1 2021 | $19,000 | -48.6% | 3,300 | -38.9% | 0.00% | -50.0% |
Q4 2020 | $37,000 | -82.7% | 5,400 | -73.0% | 0.00% | -84.6% |
Q3 2020 | $214,000 | +328.0% | 19,987 | +88.6% | 0.01% | +333.3% |
Q2 2020 | $50,000 | +35.1% | 10,600 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $37,000 | +2.8% | 10,600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $36,000 | -14.3% | 10,600 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $42,000 | +23.5% | 10,600 | 0.0% | 0.00% | +33.3% |
Q2 2019 | $34,000 | -52.8% | 10,600 | 0.0% | 0.00% | -57.1% |
Q1 2019 | $72,000 | +56.5% | 10,600 | +2.1% | 0.01% | +75.0% |
Q4 2018 | $46,000 | -41.0% | 10,384 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $78,000 | -12.4% | 10,384 | 0.0% | 0.01% | -28.6% |
Q2 2018 | $89,000 | +1.1% | 10,384 | -16.1% | 0.01% | 0.0% |
Q1 2018 | $88,000 | -25.4% | 12,384 | 0.0% | 0.01% | +40.0% |
Q4 2017 | $118,000 | -30.6% | 12,384 | +6.0% | 0.01% | -16.7% |
Q3 2017 | $170,000 | +1.8% | 11,684 | -21.1% | 0.01% | 0.0% |
Q2 2017 | $167,000 | -7.7% | 14,800 | -44.2% | 0.01% | -14.3% |
Q1 2017 | $181,000 | +15.3% | 26,500 | +52.3% | 0.01% | +40.0% |
Q4 2016 | $157,000 | +166.1% | 17,400 | -70.9% | 0.01% | +66.7% |
Q3 2016 | $59,000 | -4.8% | 59,747 | +245.4% | 0.00% | -25.0% |
Q2 2016 | $62,000 | -67.5% | 17,300 | -4.1% | 0.00% | -69.2% |
Q1 2016 | $191,000 | +48.1% | 18,047 | -49.2% | 0.01% | +62.5% |
Q4 2015 | $129,000 | – | 35,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |